Evidence map›Paper›PMID 30580157›Full record

ReviewRedox biology2019

The impact of xanthine oxidase (XO) on hemolytic diseases.

Heidi M Schmidt, Eric E Kelley, Adam C Straub

Open access · goldAbstract readReview
In one paragraph

Review in Redox biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 136 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Xanthine oxidase mediates chronic stress-induced cerebrovascular dysfunction and cognitive impairment.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Heidi M SchmidtPittsburgh Heart, Lung, Blood and Vascular Medicine Institute, United States; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, United States.
Eric E KelleyDepartment of Physiology and Pharmacology, West Virginia University, School of Medicine, Morgantown, WV, United States. Electronic address: eric.kelley@hsc.wvu.edu.
Adam C StraubPittsburgh Heart, Lung, Blood and Vascular Medicine Institute, United States; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, United States. Electronic address: astraub@pitt.edu.
University of Pittsburgh · USWest Virginia University · US

Funding

West Virginia University Stroke COBREP20GM109098 · NIGMS · WEST VIRGINIA UNIVERSITY · PI HRUSKA, MARTIN · 2014 to 2024
$24.5M
PROTEOMICSP01AG043376 · NIA · UNIVERSITY OF MINNESOTA · PI ROBBINS, PAUL D. · 2013 to 2019
$11.2M
Novel role of smooth muscle B5 reductase in Sickle Cell DiseaseR01HL133864 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STRAUB, ADAM CARL · 2016 to 2019
$2.4M
Vascular Smooth Muscle and Blood Pressure Regulation By Cyb5R3²R01HL128304 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STRAUB, ADAM CARL · 2016 to 2020
$2.4M
NHLBI NIH HHS R01 HL128304NHLBI NIH HHS R01 HL133864NIA NIH HHS P01 AG043376NIGMS NIH HHS P20 GM109098
6 · The paper itself

Abstract

Hemolytic diseases are associated with elevated levels of circulating free heme that can mediate endothelial dysfunction directly via redox reactions with biomolecules or indirectly by upregulating enzymatic sources of reactive species. A key enzymatic source of these reactive species is the purine catabolizing enzyme, xanthine oxidase (XO) as the oxidation of hypoxanthine to xanthine and subsequent oxidation of xanthine to uric acid generates superoxide (O

Indexed as

Disease SusceptibilityHemolysisAnimalsDrug DiscoveryEndothelium, VascularGene Expression RegulationHumansOxidantsOxidation-ReductionReactive Oxygen SpeciesXanthine OxidaseOxidantsReactive Oxygen SpeciesXanthine OxidaseHeme toxicityHemolysisReactive oxygen speciesTherapeuticsXanthine oxidase

Identifiers

PMID30580157
PMCPMC6305892
OpenAlexW2904769692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.